One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Healthcare ➤ Platelet Rich Plasma Market
Platelet Rich Plasma Market
Platelet Rich Plasma Market
Published date: Oct 2023 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Healthcare ➤ Platelet Rich Plasma Market

Global Platelet Rich Plasma Market- By Type (Leukocyte Rich Platelet Rich Plasma, Pure Platelet Rich Plasma, and Leukocyte Rich Platelet Rich Fibrin), By Application (Orthopedics, Cosmetic Surgery, Sports Medicine, Dermatology, Neurosurgery, and Other Applications), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032.

  • Published date: Oct 2023
  • Report ID: 35940
  • Number of Pages: 371
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • Type Analysis
    • Application Analysis
    • Origin Analysis
    • End-User Analysis
    • Key Market Segments
    • Drivers
    • Restraints
    • Opportunities
    • Trends
    • Regional Analysis
    • Key Regions
    • Key Players Analysis
    • Recent Developments
    • Report Scope

    Report Overview

    Platelet Rich Plasma Market size is expected to be worth around USD 905 Million by 2032 from USD 342 Million in 2022, growing at a CAGR of 10.5 % during the forecast period from 2023 to 2032.

    Platelet-rich plasma is created with the help of blood. When the human blood is centrifuged, platelet-rich plasma with platelet concentrations above normal values is separated, and the PRP is created. Platelets help in blood clotting and the healing of muscles, ligaments, and tendons. Platelet-rich plasma is experiencing growth due to the rising participation in sporting events, which results in rising cases of sports injuries.

    The platelet-rich plasma market was also propelling owing to the increasing research applications. An increase in the use of platelet-rich plasma for the treatment of chronic diseases like cardiovascular & neurovascular diseases, orthopedic diseases, wound management, and general surgery and rising demand for cosmetic surgeries will likely boost the growth of the market.

    Other factors, such as the increasing geriatric population, increasing adoption of PRP as an effective treatment, and rise in the occurrence of orthopedic and sports injuries, are estimated to expand the growth of the platelet-rich plasma market.

    Platelet Rich Plasma Market

    Key Takeaways

    • Platelet Rich Plasma Market Size: Expected to reach USD 905 million by 2032, with a 10.5% CAGR from 2023 to 2032.
    • PRP Growth Factors: Increasing sports participation leading to a surge in sports injuries fuels PRP market expansion.
    • Research Applications: Rising usage of PRP for various medical conditions like cardiovascular diseases, orthopedics, and cosmetic surgeries drives market growth.
    • Demographic Impact: The growing elderly population and increasing adoption of PRP therapy contribute to market expansion.
    • Dominant PRP Type: Pure platelet-rich plasma, holding over 52% market share in 2022, is known for its effectiveness and low risk.
    • Notable Type Growth: Leukocyte Rich Platelet Rich Fibrin is anticipated to grow significantly, especially in orthopedics and sports injury applications.
    • Leading Application: Orthopedics segment led the market with a 27% revenue share in 2022, offering effective treatment for chronic tendon injuries.
    • North America dominates the global PRP market, with over 42% revenue share in 2022 due to key players, high user procurement, and supportive regulatory authorities.

    Type Analysis

    Pure platelet-rich plasma Held the Highest Share of the Market

    The pure platelet-rich plasma segment accounted for the major share of this market of more than 52%, in 2022, owing to its broad use in tissue repair, the healing process, and regeneration. Pure platelet-rich plasma is mainly known for its off-label use due to these manufacturers being interested in the development of various products. PRP offers fewer adverse effects and minimum risks because of the allergic and immune response in the treatment.

    All these above-mentioned are estimated to boost the growth of the market. Leukocyte Rich Platelet Rich Fibrin will likely grow significantly due to its rising utility around orthopedic, surgery, and sports injuries. This segment is estimated to grow at the highest CAGR.

    Application Analysis

    The Orthopedics Segment Dominated the Platelet Rich Plasma Market

    The orthopedics segment accounted for the highest revenue share of 27% in 2022. Whereas, during the forecast period, other segments like sports medicine, ulcer healing, and dermatology are estimated to expand at the fastest CAGR. Compared with the conventional treatments, for effective healing in chronic tendon injuries, PRP has satisfactory results.

    In orthopedic therapeutics, PRP is remarkably used due to improved tissue repair, regeneration, and healing. Additionally, it offers soft tissue reconstruction, bone reconstruction, and long-lasting relief, which leads to the growth of the market.

    Origin Analysis

    The Autologous PRP Segment Accounted for the Largest Revenue Share

    Based on origin, the market is categorized into autologous PRP, allogeneic PRP, and homologous PRP. During the forecast period, the autologous platelet-rich segment is estimated to have the largest share of the global platelet-rich plasma market.

    End-User Analysis

    The Hospitals & Clinics Segment held the Largest Market Share

    The Hospitals and clinics segment held the highest share of the market owing to the faster growth of PRP-based therapies in the hospitals. Factors such as the high demand for non-surgical management in treatment, increasing hair loss incidences, and the increasing number of new osteoarthritis boost the growth of the market.

    Platelet Rich Plasma Market

    Key Market Segments

    Based on Type

    • Leukocyte Rich Platelet Rich Plasma
    • Pure Platelet Rich Plasma
    • Leukocyte Rich Platelet Rich Fibrin

    Based on Application

    • Orthopedics
    • Cosmetic Surgery
    • Sports Medicine
    • Dermatology
    • Neurosurgery
    • Other Applications

    Based on Origin

    • Autologous PRP
    • Allogeneic PRP
    • Homologous PRP

    Based on End-User

    • Hospitals & Clinics
    • Research Institutes
    • Other End-Users

    Drivers

    Advancement in Technologies Leads to Drive the Market Growth

    Various technological advancements in the market of platelet-rich plasma devices have led to a rise in the use of pure platelet-rich plasma in different situations and high platelet concentrations. The market also benefited due to technological breakthroughs like smart home diagnostic kits that will be estimated to boost the growth of the market.

    Increasing Prevalence of Sports Injuries

    Shoulder, knee, and elbow injuries are very common sports injuries among baseball and softball players. Sports-related injuries have increased over the past two decades, which has led to the growth of the market for platelet-rich plasma.

    Restraints

    High Cost of PRP Therapy

    The increased cost of PRP therapy hampered the growth of the PRP market during the forecast period. The problems regarding the test results and quality control will likely hinder the growth of the market in the coming years.

    Opportunities

    The Rising Demand for Plastic Surgeries

    Due to the increasing demand for plastic surgeries, the market for PRP was expanding. The PRP has evolved in plastic surgery, and it has promising results. The process includes the utilization of the body’s own natural tissue overhaul process to get improved function and form. Factors such as less or no risk of adverse reactions and ease of use are responsible for increasing the adoption of platelet-rich plasma in treatments.

    Trends

    Benefits of PRP for Skin-Related Procedures

    Platelet-rich plasma has different benefits in improving skin texture and color, lighting wrinkles depth, and skin rejuvenation. Presently, it is proved that topical application of PRP and micro-needling have improved skin tightening and collagen production. It has also grown in treating acne scars and skin pigmentation disorders.

    PRP can bind to growth factors and improve the proliferation of human derma papilla cells which leads to the formation of hair follicles in the process of hair transplantation. Hence, PRP has an increasing number of uses which leads to the growth of the market.

    Regional Analysis

    North America Dominates the Global Platelet-Rich Plasma Market During the Forecast Period

    North America accounted for the largest revenue share of over 42% in 2022. Various factors are responsible for the dominance of NA, such as the presence of key market players, high procurement at end-users like hospitals and clinics, and the presence of a huge amount of manufacturing units interested in developing novel approaches with PRP-based treatments. Also, the market growth is strengthened because the regulatory authorities are supporting and granting approvals. Due to these factors, the market growth is estimated to boost. In Europe, the tremendous revenue share was held by Germany due to reliable research facilities for PRP.

    In 2020, for instance, a survey named ‘Working Group for Clinical Tissue Generation’ was examined; it indicated the requirement for platelet-rich plasma preparation, standardization, and its application protocols for indications like knee osteoarthritis. A large number of service providers and manufacturers are present in the region, which will boost the market.

    Platelet Rich Plasma Market

    Key Regions

    • North America
      • The US
      • Canada
      • Mexico
    • Western Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Portugal
      • Ireland
      • Austria
      • Switzerland
      • Benelux
      • Nordic
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • The Czech Republic
      • Greece
      • Rest of Eastern Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Australia & New Zealand
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Colombia
      • Chile
      • Argentina
      • Costa Rica
      • Rest of Latin America
    • Middle East & Africa
      • Algeria
      • Egypt
      • Israel
      • Kuwait
      • Nigeria
      • Saudi Arabia
      • South Africa
      • Turkey
      • United Arab Emirates
      • Rest of MEA

    Key Players Analysis

    Major players are adopting strategies such as new product launches, geographical expansion, mergers & acquisitions, and partnerships in key regions. For instance, EmCyteCo. acquired Cellmedix Holdings LLC, including its Centrepid platelet concentrator system, in February 2020. This improved company’s market presence as well as product portfolio. A few key players in the market are Harvest Technologies Corporation, Medira Ltd., AdiStem Ltd., Exactech Inc., F. Hoffmann-La Roche Ltd., Biomet Holdings Inc., TERUMO BCT, INC., Trinity Biotech plc, and other market players.

    Recent Developments

    • In February 2021- Atlas Health Medical Group announced PRP Microneedling facelifts for patients.
    • In July 2021- Zimmer Biomet announced its strategic partnership with OSSIS. Zimmer Biomet is a global leader in musculoskeletal healthcare, while OSSIS is a New Zealand-based company that specifies in hip replacement treatments. The aim of the partnership is to market Zimmer Boimet’s patient-specific 3D-printed titanium hip replacement joints in APAC.

    Listed below are some of the most prominent global platelet-rich plasma market players.

    Market Key Players

    • Johnson & Johnson
    • EmCyte Corporation
    • Arthrex, Inc.
    • Juventix Regenerative Medical, LLC.
    • Zimmer Biomet
    • Apex Biologix
    • Stryker
    • Celling Biosciences, Inc.
    • Other Key Players.

    Report Scope

    Report Features Description
    Market Value (2022) US$ 342 Mn
    Forecast Revenue (2032) US$ 905 Mn
    CAGR (2023-2032) 10.5%
    Base Year for Estimation 2022
    Historic Period 2016-2022
    Forecast Period 2023-2032
    Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments Covered By Type- Leukocyte Rich Platelet Rich Plasma, Pure Platelet Rich Plasma, and Leukocyte Rich Platelet Rich Fibrin; By Application- Orthopedics, Cosmetic Surgery, Sports Medicine, Dermatology, Neurosurgery, and Other Applications; By Origin- Autologous PRP, Allogeneic PRP, and Homologous PRP; and By End-User- Hospitals & Clinics, Research Institutes, and Other End-Users.
    Regional Analysis North America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; The Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA.
    Competitive Landscape Johnson & Johnson, EmCyte Corporation, Arthrex, Inc., Juventix Regenerative Medical, LLC., Zimmer Biomet, Apex Biologix, Stryker, Celling Biosciences, Inc., and Other Key Players.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
    Platelet Rich Plasma Market
    Platelet Rich Plasma Market
    Published date: Oct 2023
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Johnson & Johnson
    • EmCyte Corporation
    • Arthrex, Inc.
    • Juventix Regenerative Medical, LLC.
    • Zimmer Biomet
    • Apex Biologix
    • Stryker Corporation Company Profile
    • Celling Biosciences, Inc.
    • Other Key Players.
  • settingsSettings

Related Reports

  • Mycoplasma Testing Market
  • Plasma Fractionation Market
  • Regenerative Medicine Market
  • Vitamin D Testing Market
  • Triathlon Clothing Market
  • Special Purpose Needles Market

Our Clients

  • Our Clients
Inquiry Before Buying

Platelet Rich Plasma Market
  • 35940
  • Oct 2023
    • ★★★★★
      ★★★★★
    • (46)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.